Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy - PubMed. Haber 🤔 https://t.co/DVIeDk4iv0
New NNT→Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy. https://t.co/u8YH6rzbOL
Desfibriladores cardíacos implantables para personas con cardiomiopatía no isquémica: disminuyen la mortalidad por todas las causas y las muertes cardíacas repentinas, y probablemente por causas cardiovasculares en comparación con la terapia médica sola. h
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
RT @paomorejon: 📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more be…
📌ICD for people with non-ischaemic cardiomyopathy 🔗ICD+OMT🆚OMT All-cause mortality HR 0.78, 95%CI 0.66 to 0.92 🔗<65 more benefit: HR 0.51, 95% CI 0.29 to 0.91 🔗ICD therapy probably has little or no effect on quality of life @cochranecollab #CardioEd ht
RT @CochraneHeart "Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy - El Moheb, M - 2018 | Cochrane Library https://t.co/ZCsAcR98Kd … @cochranecollab @WileyCardiology"
RT @DrMarwanRefaat: Our publication in @CochraneLibrary @cochranecollab :ICD in Non-ischemic #heartfailure @CochraneHeart @CochraneUK @Elie…
RT @DrMarwanRefaat: Our publication in @CochraneLibrary @cochranecollab :ICD in Non-ischemic #heartfailure @CochraneHeart @CochraneUK @Elie…
RT @DrMarwanRefaat: Our publication in @CochraneLibrary @cochranecollab :ICD in Non-ischemic #heartfailure @CochraneHeart @CochraneUK @Elie…
RT @DrMarwanRefaat: Our publication in @CochraneLibrary @cochranecollab :ICD in Non-ischemic #heartfailure @CochraneHeart @CochraneUK @Elie…
RT @CochraneHeart: Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy - El Moheb, M - 2018 | Cochrane Library…
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy - El Moheb, M - 2018 | Cochrane Library https://t.co/phaluMDeuZ @cochranecollab @WileyCardiology
Our publication in @CochraneLibrary @cochranecollab :ICD in Non-ischemic #heartfailure @CochraneHeart @CochraneUK @Elie__Akl @ElmohebM @AssemMKhamis @FuadZiyadeh @DrFadloKhuri @omwazni @aalahmadmd @MoussaMansour10 @DrBradleyKnight @keaglemd @EvidenceBsdMed
RT @ElmohebM: Is there a benefit of implanting #ICD in patients with non-ischaemic #heartfailure ? Our #Cochrane review seems to think so!…
RT @ElmohebM: Is there a benefit of implanting #ICD in patients with non-ischaemic #heartfailure ? Our #Cochrane review seems to think so!…
Is there a benefit of implanting #ICD in patients with non-ischaemic #heartfailure ? Our #Cochrane review seems to think so! Full paper: https://t.co/RIBCFivO7M @DrMarwanRefaat @Elie__Akl @AssemMKhamis @johnynicolas1
RT @AssemMKhamis: The 1st Cochrane Systematic Review https://t.co/d38q8yL9zE Publication #11 https://t.co/ZZEE0JAiFj #Biostatistics #Bio…
RT @AssemMKhamis: The 1st Cochrane Systematic Review https://t.co/d38q8yL9zE Publication #11 https://t.co/ZZEE0JAiFj #Biostatistics #Bio…
The 1st Cochrane Systematic Review https://t.co/d38q8yL9zE Publication #11 https://t.co/ZZEE0JAiFj #Biostatistics #BiostatBeirut https://t.co/AMIptXyzva